These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28852801)

  • 1. A model-based assay design to reproduce in vivo patterns of acute drug-induced toxicity.
    Kuepfer L; Clayton O; Thiel C; Cordes H; Nudischer R; Blank LM; Baier V; Heymans S; Caiment F; Roth A; Fluri DA; Kelm JM; Castell J; Selevsek N; Schlapbach R; Keun H; Hynes J; Sarkans U; Gmuender H; Herwig R; Niederer S; Schuchhardt J; Segall M; Kleinjans J
    Arch Toxicol; 2018 Jan; 92(1):553-555. PubMed ID: 28852801
    [No Abstract]   [Full Text] [Related]  

  • 2. Microdosing for reduction of the time and resources for drug development.
    Sudo K
    Drug Metab Pharmacokinet; 2007 Oct; 22(5):327. PubMed ID: 17965515
    [No Abstract]   [Full Text] [Related]  

  • 3. New technologies in drug metabolism and toxicity screening: organ-to-organ interaction.
    Bhushan A; Martucci NJ; Usta OB; Yarmush ML
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):475-7. PubMed ID: 26940609
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose selection for toxicity studies: a protocol for determining the maximum repeatable dose.
    Spurling NW; Carey PF
    Hum Exp Toxicol; 1992 Nov; 11(6):449-57. PubMed ID: 1361132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose toxicity and repeated dose toxicity studies: introductory remarks.
    Kurokawa Y; Matsuzawa T
    J Toxicol Sci; 1996 Dec; 21(5):413-6. PubMed ID: 9035047
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
    Kågström J; Sjögren EL; Ericson AC
    J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish.
    Cornet C; Calzolari S; Miñana-Prieto R; Dyballa S; van Doornmalen E; Rutjes H; Savy T; D'Amico D; Terriente J
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic approaches to toxicology in the zebrafish.
    Peterson RT; Macrae CA
    Annu Rev Pharmacol Toxicol; 2012; 52():433-53. PubMed ID: 22017682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.
    Thiel C; Cordes H; Conde I; Castell JV; Blank LM; Kuepfer L
    Arch Toxicol; 2017 Feb; 91(2):865-883. PubMed ID: 27161439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human-based in vitro experimental systems for the evaluation of human drug safety.
    Li AP
    Curr Drug Saf; 2007 Sep; 2(3):193-9. PubMed ID: 18690967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs in control samples in nonclinical safety studies: a reconsideration.
    Zimmer D
    Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative evaluation of pharmacological effects and adverse effects based on receptor occupancy theory].
    Sawada Y; Yamada Y; Iga T
    Yakugaku Zasshi; 1997 Feb; 117(2):65-90. PubMed ID: 9084225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic drug reactions.
    Perez V; Schaffner F; Popper H
    Prog Liver Dis; 1972; 4():597-625. PubMed ID: 4569012
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
    Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
    Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
    Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver.
    Kitamura S; Sugihara K
    Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico methods to predict drug toxicity.
    Roncaglioni A; Toropov AA; Toropova AP; Benfenati E
    Curr Opin Pharmacol; 2013 Oct; 13(5):802-6. PubMed ID: 23797035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of drug metabolites.
    Izumi T
    Drug Metab Pharmacokinet; 2011; 26(2):121-2. PubMed ID: 21532211
    [No Abstract]   [Full Text] [Related]  

  • 19. Early drug safety evaluation: biomarkers, signatures, and fingerprints.
    Roberts R; Cain K; Coyle B; Freathy C; Leonard JF; Gautier JC
    Drug Metab Rev; 2003 Nov; 35(4):269-75. PubMed ID: 14705860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
    Tsaioun K; Jacewicz M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.